BRCA1 p.Gln1811Ter
c.5431C>T · rs397509283 · VCV55577
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function in a haploinsufficient gene (ClinGen) |
|---|---|---|
| NMD | escapes | premature termination codon within the last 50 nt of the penultimate exon (22 of 23, 36 nt from its 3' end) — the truncated protein is likely expressed. PVS1 input, not an applied code |
| REVEL | 0.39 | indeterminate |
| Splicing | ||
| SpliceAI | Δ0.38 | acceptor loss, 24 bp away · raw score · deltas |
| Pangolin | Δ0.52 | loss · gain 0.00 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 7.3 | GERP 0.49, phastCons 1 |
| Overall | ||
| CADD | 39.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BRCA1
- Protein
- p.Gln1811Ter
- Coding
- c.5431C>T
- MANE Select
- NM_007294
- dbSNP
- rs397509283
- Type
- single nucleotide variant
- Location
- chr17:43047679 (GRCh38)
- Gene constraint
- LOEUF 0.885 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 41.99 · 33 PDB
- Residue 1811
- a UniProt-annotated variant site (in fancs); the brct 2 domain
Disease context
breast-ovarian cancer, familial, susceptibility to, 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: urinary bladder cancerhereditary breast ovarian cancer syndromepancreatic cancer, susceptibility to, 4hereditary neoplastic syndromehereditary breast carcinoma
For Hereditary breast and/or ovarian cancer syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult, Elderly
Similar variants
- BRCA1 p.Gln1811Arg Pathogenic/Likely pathogenic ★★ ⚠ same residue
- BRCA1 p.Gln1811Pro Likely pathogenic ★ ⚠ same residue
- BRCA1 p.Gln1811His Uncertain significance ★ ⚠ same residue
- BRCA1 p.Gln1811Lys Conflicting classifications of pathogenicity ★ ⚠ same residue
- BRCA1 p.Gln1811fs Pathogenic/Likely pathogenic ★★ same residue
- BRCA1 c.134+3A>T Likely pathogenic ★★★ same condition
- BRCA1 c.135-1G>T Pathogenic ★★★ same condition
- BRCA1 c.212+1G>A Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca1-p-gln1811ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown